Neurochemical 2024

9 papers
The 2024 edition of Neurochemical features research focused on the molecular mechanisms of neurodegenerative diseases and potential therapeutic interventions. A prominent theme throughout the year's nine publications is the role of ferroptosis, with studies investigating its impact on Parkinson’s disease, amyotrophic lateral sclerosis (ALS), and ischemic stroke. Researchers explored specific signaling pathways, such as Nrf2/GPX4 and Akt/mTOR, to understand how cellular processes like autophagy and programmed cell death contribute to neurological conditions. Specific contributions include investigations into the effects of lead (Pb) exposure on hippocampal signaling and the sedative properties of cannabidiol via the 5-HT1A receptor in insomnia models. Other work examined the clinical prospects of mitochondrial DNA polymorphisms in neurodegeneration and the function of brain-derived neurotrophic factor within the vestibular-cochlear system. Prolific contributors to this year's research include Michael Aschner, Huishuai Li, and Yang Xiang. These studies collectively emphasize the intersection of biochemical pathways and clinical applications in treating brain disorders and gliomas.

Top Research Directions

The 6 research directions with Neurochemical 2024 papers, ranked by paper count. Share is the fraction of the edition’s papers in the direction.

#DirectionPapersShare
1Dual In Vitro and In Vivo Experimental Frameworks111.1%
2Overcoming the Pharmacokinetic Characterization Gap111.1%
3The Molecular Mechanics of Iron Dependent Cell Death111.1%
4The Sustainability Gap in Short-Term Clinical Evaluations111.1%
5The Transition to Disease-Modifying Therapies in Neurodegeneration111.1%
6Transcriptional Regulation of Cellular Redox Homeostasis via Nrf2111.1%

Download all directions as CSV

Institutions

Institutions credited by Neurochemical 2024 papers: a paper credits every institution named in its affiliations, once. 1 institutions share 1 credited papers.

#InstitutionPapersShare
1059cjpv64 1100.0%

Download all institutions as CSV

About this data

Papers. Neurochemical 2024 lists 9 papers on Lacuna, duplicate versions counted once; rejected and withdrawn submissions are left out.

Directions. Directions are Lacuna’s clustering of the concept elements extracted from each paper, so a paper can belong to several and direction counts add up to more than the paper count. A direction’s share is its papers divided by the edition’s papers.

Institutions. A paper credits each institution named in its affiliations, resolved to a ROR record, once. 1 of 9 papers (11.1%) credit at least one institution and are the base for institution shares; the rest have no resolved affiliation yet.

Data. Counts come from Lacuna’s data build of 2026-11-19 and change as papers are added. Tables as CSV: directions · institutions. Cite as: Lacuna, “Neurochemical 2024”, https://lacuna.tiptreesystems.com/venue/neurochemical/2024.

Papers

Title
A New Perspective in the Treatment of Ischemic Stroke: Ferroptosis
Cannabidiol Exerts Sedative and Hypnotic Effects in Normal and Insomnia Model Mice Through Activation of 5-HT1A Receptor
Dexmedetomidine Promotes NREM Sleep by Depressing Oxytocin Neurons in the Paraventricular Nucleus in Mice
Function of Brain-Derived Neurotrophic Factor in the Vestibular-Cochlear System
Knockdown of PRR11 Induces Autophagy in Glioma Cells by Inhibiting Akt/mTOR Signaling Pathway
Mechanism and Clinical Application Prospects of Mitochondrial DNA Single Nucleotide Polymorphism in Neurodegenerative Diseases
Salidroside Mediated the Nrf2/GPX4 Pathway to Attenuates Ferroptosis in Parkinson’s Disease
The Effects of Pb on TNF-R1-RIPK1/RIPK3 Signaling Pathway in the Hippocampus of Mice
The Role of Ferroptosis in Amyotrophic Lateral Sclerosis Treatment